DSM Nutritional Products agreed to acquire Pentapharm last month. A purchase price was not disclosed. Pentapharm, headquartered in Basel, Switzerland with sales revenues around $55 million, employs people in Switzerland, Japan and Brazil. Pentapharm holds a global position in the development and production of active ingredients and system solutions for the personal care industry. According to DSM, Pentapharm’s patent-protected cosmetic active ingredients meet consumers’ increasing demand...